Home / Inspections / 1035563

FDA Inspection 1035563 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on January 28, 2016 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 28, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Clayton, NC (United States)

Facility

Other inspections at this facility

  • 1269778 (NAI Fri Jun 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041878 (NAI Fri Jan 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892098 (NAI Thu Aug 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802592 (NAI Thu Aug 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734383 (NAI Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources